Innovative Pharmaceutical Biotech ( (HK:0399) ) just unveiled an announcement.
Innovative Pharmaceutical Biotech Limited has entered into a Memorandum of Understanding (MOU) with Conflux to explore potential cooperation on blockchain infrastructure and technologies. This collaboration could lead to the development of new technologies and application scenarios, with possible equity cooperation, although it remains subject to a formal agreement. The company will conduct due diligence on Conflux’s technologies and intends to finalize a formal agreement within six months, while maintaining exclusivity in negotiations for up to 12 months.
More about Innovative Pharmaceutical Biotech
Innovative Pharmaceutical Biotech Limited is a company incorporated in the Cayman Islands and continued in Bermuda, focusing on the pharmaceutical and biotechnology industry. The company is exploring expansion into blockchain technology, aiming to integrate innovative technologies into its operations.
Average Trading Volume: 940,657
Technical Sentiment Signal: Sell
Current Market Cap: HK$326.2M
Find detailed analytics on 0399 stock on TipRanks’ Stock Analysis page.